ArticleNeuro-ophthalmology (Aeolus Press)2019
Ophthalmic Manifestations of Posterior Reversible Encephalopathy Syndrome.
Article in Neuro-ophthalmology (Aeolus Press), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 24 citations in OpenAlex.
- Acute Bilateral Vision Loss in Pregnancy: A Case of Posterior Reversible Encephalopathy Syndrome.Cureus · 2026Article
- From Gut to Gray Matter: A Case Report of Posterior Reversible Encephalopathy Syndrome in a Pediatric Patient With Celiac Disease.Clinical case reports · 2025Article
- Reversible postoperative vision loss (POVL): A tale of four patients.Qatar medical journal · 2024Article
- Posterior Reversible Encephalopathy Syndrome in the Immediate Postoperative Period of Gastric Cancer.Cureus · 2023Article
- Amaurosis Fugax in Posterior Reversible Encephalopathy Syndrome: A Vexed Hurdle in a Postpartum Primigravida Patient.Cureus · 2023Article
- Hindsight is 20/20, an unexpected ocular telltale sign of bilateral renal artery dissection.American journal of ophthalmology case reports · 2023Article
- Posterior reversible encephalopathy syndrome-associated bilateral cortical blindness as presenting feature of severe pre-eclampsia.BMJ case reports · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Posterior reversible encephalopathy syndrome (PRES) is a condition of neurotoxicity that presents with a sudden onset of symptoms including headache, altered mental status, seizures, and visual disturbances. Monitoring visual symptoms in PRES is critical as visual deficits are found in nearly 40% of patients. This paper aims to identify the visual symptoms associated with PRES and determine visual outcomes following treatment. While the symptoms of PRES are alarming, the disease is typically reversible once the cause is eliminated. Our findings suggest that those who present with ocular complaints can be reassured that their symptoms will improve, if not completely resolve.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.